MZMusa Moetasam Zorab

Musa Moetasam Zorab

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Musa Moetasam Zorab has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mitochondrial Dysfunction as a Context‐Dependent Driver and Amplifier of the SASP : Targeting the mtDNA – cGAS – STING Axis for Next‐Generation Senotherapeutics

    by Hamza Kamaran Hama, Mohammed Ali Hama, Musa M. Zorab, Amirreza Gholami, Ammar Mohammed Al‐Farga

    Cellular senescence combines stable cell‐cycle arrest with mitochondrial and innate immune remodelling that shapes the senescence‐associated secretory phenotype (SASP). This narrative review evaluates mitochondrial dysfunction as a context‐dependent initiator or amplifier of senescence and examines mitochondrial DNA (mtDNA) sensing through cGAS–STING as a driver of SASP regulation. We distinguish mitochondrial damage, cytosolic mtDNA exposure, pathway activation, SASP transcription, secretion, paracrine activity and tissue outcomes as separate levels of evidence. The strongest mechanistic studies link BAX/BAK‐mediated minority mitochondrial outer‐membrane permeabilization, VDAC1 oligomerization, defective mitophagy or abnormal mtDNA composition to cytosolic mtDNA, cGAS–STING activation and SASP modulation through genetic or pharmacological perturbation. However, pathway architecture varies across cell types, tissues and senescence triggers, and nuclear DNA, micronuclei, retroelements and mitochondrial RNA can activate overlapping inflammatory programmes. Preclinical evidence therefore supports STING inhibition primarily as a senomorphic, anti‐inflammatory and tissue‐protective strategy rather than a senolytic intervention. Mitophagy enhancement, inhibition of mtDNA release, targeted protein degradation and precision delivery offer complementary approaches, but human efficacy remains unestablished. Clinical translation will require standardized biomarkers, biologically informed patient selection, pharmacodynamic confirmation, tissue‐restricted or reversible modulation and prospective assessment of antiviral, antitumour and long‐term safety. Overall, the mitochondrial dysfunction–mtDNA–cGAS–STING axis is a mechanistically credible but context‐dependent therapeutic framework whose clinical value will depend on validated pathway engagement and appropriately timed clinical intervention.

  • Saccharin Revisited: Chemistry, Metabolism, Toxicology and Human Health Risk Assessment in the Era of Evidence‐Based Food Safety

    by Amjad Mahmood Qadir, Azad Mohammed Aziz Ahmed, Musa M. Zorab, Rebaz Anwar Omer

    Saccharin is one of the oldest and most extensively used nonnutritive sweeteners, valued for its intense sweetness, chemical stability and negligible caloric contribution. Since its discovery in 1879, it has been widely incorporated into foods, beverages, pharmaceuticals and personal care products, while its safety has remained the subject of considerable scientific and regulatory debate. Early experimental studies linking saccharin to bladder tumour formation in rodents raised concerns regarding its carcinogenic potential; however, subsequent mechanistic investigations, epidemiological evidence and comprehensive risk assessments have demonstrated that these findings are species‐specific and not directly applicable to humans. This review provides a comprehensive and critical synthesis of current knowledge on saccharin, encompassing its chemical characteristics, physicochemical properties, industrial and pharmaceutical applications, absorption, metabolism, excretion and toxicological profile. Particular emphasis is placed on evaluating evidence related to carcinogenicity, genotoxicity, metabolic effects, oxidative stress, gut microbiota interactions and other emerging health concerns through the integration of experimental, clinical and population‐based studies. In addition, the review examines the scientific basis of international regulatory decisions, discusses the challenges of translating animal toxicology findings into human health risk assessment and identifies persistent knowledge gaps requiring further investigation. Current evidence consistently supports the safety of saccharin when consumed within established acceptable daily intake limits established by international regulatory agencies. Nevertheless, well‐designed long‐term human studies and mechanistic investigations remain necessary to better define its potential effects on metabolic health, the gut microbiome and susceptible populations. By integrating historical evidence with contemporary advances in toxicology and regulatory science, this review provides an updated framework for understanding the safety, biological effects and public health implications of saccharin consumption.

  • Open Access

    Campylobacter jejuni Across the Food Chain: Integrating Pathogenesis, Persistence, Antimicrobial Resistance, and Emerging One Health Control Strategies

    by Othman Abdulrahman Mohammed, Mohammed Ali Hama, Saman A. Mohammed, Musa Muatasam Zorab, Suhaib H. Kakamad, Hazha Hassan Tahir, Amirreza Gholami, Azad Mohammed Aziz, Hamza Kamaran Hama, Kawther Hoshear Faiq, et al.

    Campylobacter jejuni continues to be a globally important foodborne pathogen and is one of the most common bacterial causes of gastroenteritis in humans. This fastidious microaerophilic organism is seldom cultured outside of animal hosts, yet it repeatedly populates poultry, livestock, water, processing environments, retail foods, domestic kitchens, and humans. Here, we critically integrate the evidence in a transmission‐connected, farm‐to‐fork pathway spanning colonization of animal reservoirs and carcass contamination to environmental persistence, human exposure, and disease (including antimicrobial resistance), detection, and intervention. In many systems, asymptomatic, high‐density colonization of poultry is the main amplification reservoir and carcass cross‐contamination, mixed‐species biofilms, aerotolerance, oxidative‐stress defense, cold survival, and viable‐but‐nonculturable cells support persistence through processing and distribution. Coordinated motility, chemotaxis, adhesion, disruption of epithelial barrier functions, invasion, and cytolethal distending toxin activity contribute to epithelial injury and inflammation, whereas lipooligosaccharide‐mediated molecular mimicry contributes to postinfectious complications. Factors such as persistent target‐site mutations, CmeABC efflux, acquired determinants, and antimicrobial selection within One Health compartments continue to sustain resistance to fluoroquinolones, tetracyclines, and macrolides in certain settings. Because no single point intervention can sufficiently control transmission across the food chain, effective risk reduction relies on a portfolio of components such as whole‐farm biosecurity, biological control, hygienic processing and handling, cold‐chain management, consumer hygiene interventions at home, antimicrobial stewardship, viability‐sensitive detection and genomic surveillance. These findings are consistent with multihurdle control strategies and integrated One Health surveillance linking both animal, food, environmental, and human health sectors. Consequently, future policy and research initiatives should ideally focus on harmonized sampling and surveillance protocols, standardized outcomes of intervention studies, validation at the commercial scale and evidence directly relating C. jejuni reductions to risk of human disease.

  • Open Access

    Protective effects of Allium stipitatum Regel. extract against streptozotocin-induced cytotoxicity in pancreatic beta cells: Implications for diabetes management

    by Musa Moetasam Zorab

    Introduction: Allium stipitatum is used against diabetes but its protective effects on beta cells remain unclear. This study investigated the cytoprotective and antioxidative effects of A. stipitatum extract in a streptozotocin (STZ)-induced beta-cell injury model. Methods: Allium stipitatum methanol extract was prepared and tested at 10 µg/mL on cultured pancreatic beta cells, alone or in combination with STZ (100 µM). Cell viability (Trypan blue test), insulin secretion (ELISA), nitric oxide (NO) levels (Griess method), and total antioxidant capacity (FRAP assay) were evaluated. Data were analyzed using one-way analysis of variance (ANOVA) with Tukey’s test (P<0.05). Results: STZ significantly reduced insulin secretion (From 45.7±0.38 to 21.47 ± 0.78 mU/L) (P<0.05) in STZ group, while A. stipitatum extract increased it to 40.7 ± 0.41 mU/L (P<0.05) in the extract group. Additionally, in all four groups where the extract was applied (extract, extract + STZ (pre-treatment), STZ + extract (post-treatment), and extract – STZ (co-treatment), the extract increased insulin secretion levels. Beta-cell viability declined with STZ (From 33633±1537 to 11500 ± 577 cells) but improved with extract treatment to 26500 ± 1626 (P<0.05). Although the extract did not significantly enhance total antioxidant capacity, it markedly reduced NO levels, particularly in extract + STZ group (P<0.05). Conclusion: Allium stipitatum extract supports beta-cell survival and insulin secretion in STZ-induced pancreatic damage, indicating potential therapeutic applications in diabetes management. Further studies are needed to identify active compounds and optimize its use.

  • Open Access

    Effect of Serum Lipid Profile and Renal Functions during Pregnancy and its associated diseases in Sulaimanyah / Kurdistan Region

    by Azad Mohammed Aziz Ahmed, Amjad Mahmood Qadir, Jamal Kareem Shakor, Musa M. Zorab

    Background and Objective: The physiological function of the kidneys poses significant challenges during pregnancy, impacting maternal and fetal health. Understanding the interplay between renal functions and serum lipid profiles is crucial for managing maternal health. This study aims to investigate serum lipid profiles and their association with renal function in pregnancy and compare them with non-pregnant status. The objective of this study was to conduct a prospective analysis of blood lipid concentration, namely lipoprotein, as well as the rates of urea and creatinine, in pregnant women, and thereafter compare these measurements with those of non-pregnant women. Methods: A case- control study was conducted on pregnant women in Sulaimanyah/Kurdistan. Both serum lipid profile tests, including triglycerides, cholesterol, and lipoprotein levels, and renal function markers, such as serum creatinine, urea, and estimated glomerular filtration rate, were measured at various stages of pregnancy. Data was analyzed by the Statistical Package for the Social Sciences version 22.0 to identify correlations between serum lipid profile, renal function, and pregnancy outcomes. Results: This study highlights significant positive correlations of low-density lipoprotein with gestation age, cholesterol, triglyceride, and high-density lipoprotein, alongside strong negative correlations with total serum bilirubin and creatinine in pregnancy. This correlation was not found in non-pregnant status. Additionally, estimated glomerular filtration rate exhibits strong positive correlations with cholesterol and low-density lipoprotein and negative correlations with total serum bilirubin and creatinine.In non-pregnant individuals, estimated glomerular filtration rate moderately correlates with random blood sugar while strongly correlating negatively with urea and creatinine.Mean ± Standard deviation of urea and creatinine were significantly higher in non-pregnant women while cholesterol and estimated glomerular filtration rate were significantly high among pregnant women. Conclusion: This study highlighted notable metabolic disparities between pregnant and non-pregnant women, particularly in terms of lipid profiles and renal function.


  • Open Access

    Comparative molecular docking and toxicity between carbon-capped metal oxide nanoparticles and standard drugs in cancer and bacterial infections

    by Navid Mohammadjani, Sahand Karimi, Musa Moetasam Zorab, Morahem Ashengroph, Mehran Alavi

    Introduction: Nanoparticles (NPs) are of great interest in the design of various drugs due to their high surface-to-volume ratio, which result from their unique physicochemical properties. Because of the importance of examining the interactions between newly designed particles with different targets in the case of various diseases, techniques for examining the interactions between these particles with different targets, many of which are proteins, are now very common. Methods: In this study, the interactions between metal oxide nanoparticles (MONPs) covered with a carbon layer (Ag2O3, CdO, CuO, Fe2O3, FeO, MgO, MnO, and ZnO NPs) and standard drugs related to the targets of Cancer and bacterial infections were investigated using the molecular docking technique with AutoDock 4.2.6 software tool. Finally, the PRO TOX-II online tool was used to compare the toxicity (LD50) and molecular weight of these MONPs to standard drugs. Results: According to the data obtained from the semi flexible molecular docking process, MgO and Fe2O3 NPs performed better than standard drugs in several cases. MONPs typically have a lower 50% lethal dose (LD50) and a higher molecular weight than standard drugs. MONPs have shown a minor difference in binding energy for different targets in three diseases, which probably can be attributed to the specific physicochemical and pharmacophoric properties of MONPs. Conclusion: The toxicity of MONPs is one of the major challenges in the development of drugs based on them. According to the results of these molecular docking studies, MgO and Fe2O3 NPs had the highest efficiency among the investigated MONPs.


  • Open Access

    Biosynthesis of Quantum Dots and Their Therapeutic Applications in the Diagnosis and Treatment of Cancer and SARS-CoV-2

    by Musa Moetasam Zorab, Navid Mohammadjani, Morahem Ashengroph, Mehran Alavi

    Quantum dots (QDs) are semiconductor materials that range from 2 nm to 10 nm. These nanomaterials (NMs) are smaller and have more unique properties compared to conventional nanoparticles (NPs). One of the unique properties of QDs is their special optoelectronic properties, making it possible to apply these NMs in bioimaging. Different size and shape QDs, which are used in various fields such as bioimaging, biosensing, cancer therapy, and drug delivery, have so far been produced by chemical methods. However, chemical synthesis provides expensive routes and causes serious environmental and health issues. Therefore, various biological systems such as bacteria, fungi, yeasts, algae, and plants are considered as potent eco-friendly green nanofactories for the biosynthesis of QDs, which are both economic and environmentally safe. The review aims to provide a descriptive overview of the various microbial agents for the synthesis of QDs and their biomedical applications for the diagnosis and treatment of cancer and SARS-CoV-2.